Lydia G. Olson, Ph.D. is an associate in the Intellectual Property Department and a member of the Life Sciences practice group. Her practice focuses primarily on patent prosecution and portfolio management in a variety of fields in the life science and chemical industries.
Specific areas of expertise include chemistry (i.e., small molecule synthesis, catalysts, polymers coatings, polymeric particles, nanotechnology, and semiconductors); biotechnology (i.e., proteins, nucleic acids, tissue generation); pharmaceuticals (i.e., drug products, formulations, polymorphs, drug conjugates, drug delivery, and dosage forms,); and devices (i.e., spectroscopy and spectrometry instrumentation and methods, lab-on-a-chip devices, diagnostic, high-throughput screening, and medical devices).
Dr. Olson has experience in U.S. and foreign patent procurement, due diligence, licensing and opinion counseling. Dr. Olson gained prior experience while working at the Pacific Northwest National Laboratory in a post-doctoral appointment with the Environmental and Molecular Sciences Laboratory.
While obtaining her Ph.D., Dr. Olson was the recipient of a National Institutes of Health Biotechnology training grant through the Center for Biopolymers at Interfaces. Her thesis research involved the use of Surface-Enhanced Raman Spectroscopy to study kinetics at the liquid-solid interface.